Global In-Vitro Fertilization Market Sized By Reagents (OVUM processing media, Sperm processing media, Cryopreservation media, Embryo culture media) By Equipment (Sperm separation system, OVUM aspiration pumps, Cabinets, Incubators, Micromanipulator system, Gas analyzers, Cryosystems, and others) By End Use (Fertility centers, hospitals, Cryobanks, research laboratories) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Global In-Vitro Fertilization Market was valued at US$ 16,744.0 million in 2018 and is estimated to reach US$ 37,240.0 million by 2027, growing at a CAGR of 9.3% over the forecast period.
Global In-Vitro Fertilization Market Revenue (USD Million), 2015 - 2027
Globally, the growing cases of infertility among both genders, rise in IVF success ratio, and technological advancements in the procedures and devices are the prominent growth drivers for in-vitro fertilization market.
Strong government intent played an important role in creating a conducive environment for market growth. Earlier, in December 2016, the Ontario state government disbursed US$ 50 million for the fertility programs for 5,000 people seeking in-vitro fertilization treatment. Moreover, Singapore government provides incentives for Assisted Reproductive Technology (ART) procedures. Incentives include 75% co-funding for the ART procedures, such as IVF, Intra-cytoplasmic Sperm Injection (ICSI), and Gamete Intra-fallopian Transfer (GIFT).
The growth in the in-vitro fertilization market is projected to be driven by an increase in gamete donations, delay in women pregnancies, and on-going research and funding. Team of researchers from Brigham & Women’s Hospital in collaboration with Peking University and Yikon Genomics developing precise pre-implantation genetic test for the development of IVF embryos. This will help in selecting embryos for IVF. However, the cost of treatment, ethical concerns and probable side effects are anticipated to limit market growth to a certain extent.
On the basis of reagent, the market is bifurcated as ovum processing media, sperm processing media, embryo culture media, and Cryo-preservation media. Embryo culture media is projected to hold the largest share in the in-vitro fertilization market and also anticipated to grow at the highest rate over the study period. High segmental share is attributed to increase in awareness among individuals regarding infertility treatment and diagnosis.
On the basis of equipment, the market is segmented into ovum aspiration pumps, sperm separation systems, incubators, cabinets, micro-manipulators systems, Cryosystems, gas analyzers, and others. Sperm separation systems are anticipated to have highest growth, owing to rise in sperm donations for IVF procedures.
On the basis of end user, the market is segmented as hospitals, fertility centers, Cryobanks, and research laboratories. Fertility centers accounted for largest share in the global market. High share is attributed to increase in number of fertility centers, across the globe.
North America in-vitro fertilization market, held largest market share and is estimated to hold its dominance in the years to come. High average household income, increase in affordability rates, and access to healthcare are the major reasons behind rising demand for the across the region.
Asia Pacific in-vitro fertilization market is anticipated to grow rapidly owing to the presence of huge population suffering from infertility across the region. With the burgeoning cost of IVF procedures in the developed countries, India and China became hub for the fertility tourism, which bound to boost adoption of IVF procedures in the respective countries.
The report provides both, qualitative and quantitative research of global in-vitro fertilization market, it also provides penetrative insights into the rational scenario and favored development methods adopted by key contenders. The report also offers extensive research on the key players in the market and detailed insights into the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by major players are also recognized and analyzed in the report. For each company, the report recognizes its headquarter, competitors, product/service type, application and specification, pricing, and gross margin.
Competitive Landscape
Major industry participants in the global in-vitro fertilization market include Cook Medical Inc., FUJIFILM Irvine Scientific Inc., Ginea Biomedx, Thermofisher Scientific Inc., Vitrolife, The Baker Company Inc., Kitazato Corporation, Rocket Medical Plc., Hamilton Torne Inc., and Green IVF. New product launches, merger and acquisition, geographical expansion are some of the major strategies adopted by these players to gain a competitive edge.
- By Reagents
- Ovum Processing Media
- Sperm Processing Media
- Cryopreservation Media
- Embryo Culture Media
- By Equipment
- Sperm Separation Systems
- Ovum Aspiration Pumps
- Cabinets
- Incubators
- Micromanipulator Systems
- Gas Analyzers
- Cryosystems
- Others
- By End Use
- Fertility Centers
- Hospitals
- Cryobanks
- Research Laboratories
- By Geography
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Argentina
- Brazil
- Rest of Latin America
- North America
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of In-Vitro Fertilization Market
6. Market Synopsis:
In-Vitro Fertilization Market
7. In-Vitro Fertilization
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
In-Vitro Fertilization Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: In-Vitro Fertilization Market
7.6. Industry
Gross Margin Overview
7.7. Porter’s
Five Force Analysis
8. Global In-Vitro Fertilization
Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
In-Vitro Fertilization Market Revenue
(US$ Mn)
8.2. Global
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Reagents
8.2.1. OVUM
Processing Media
8.2.1.1. Definition
8.2.1.2. Market Penetration, 2018
8.2.1.3. Market Estimation, 2013 – 2018
8.2.1.4. Market Forecast, 2019 – 2027
8.2.1.5. Compound Annual Growth Rate (CAGR)
8.2.1.6. Regional Bifurcation
8.2.1.6.1. North America
8.2.1.6.1.1. Market
Estimation, 2013 – 2018
8.2.1.6.1.2. Market
Forecast, 2019 – 2027
8.2.1.6.2. Europe
8.2.1.6.2.1. Market
Estimation, 2013 – 2018
8.2.1.6.2.2. Market
Forecast, 2019 – 2027
8.2.1.6.3. Asia Pacific
8.2.1.6.3.1. Market
Estimation, 2013 – 2018
8.2.1.6.3.2. Market
Forecast, 2019 – 2027
8.2.1.6.4. Middle East and Africa
8.2.1.6.4.1. Market
Estimation, 2013 – 2018
8.2.1.6.4.2. Market
Forecast, 2019 – 2027
8.2.1.6.5. Latin America
8.2.1.6.5.1. Market
Estimation, 2013 – 2018
8.2.1.6.5.2. Market
Forecast, 2019 – 2027
8.2.2. Sperm
Processing Media
8.2.2.1. Definition
8.2.2.2. Market Penetration, 2018
8.2.2.3. Market Estimation, 2013 – 2018
8.2.2.4. Market Forecast, 2019 – 2027
8.2.2.5. Compound Annual Growth Rate (CAGR)
8.2.2.6. Regional Bifurcation
8.2.2.6.1. North America
8.2.2.6.1.1. Market
Estimation, 2013 – 2018
8.2.2.6.1.2. Market
Forecast, 2019 – 2027
8.2.2.6.2. Europe
8.2.2.6.2.1. Market
Estimation, 2013 – 2018
8.2.2.6.2.2. Market
Forecast, 2019 – 2027
8.2.2.6.3. Asia Pacific
8.2.2.6.3.1. Market
Estimation, 2013 – 2018
8.2.2.6.3.2. Market
Forecast, 2019 – 2027
8.2.2.6.4. Middle East and Africa
8.2.2.6.4.1. Market
Estimation, 2013 – 2018
8.2.2.6.4.2. Market
Forecast, 2019 – 2027
8.2.2.6.5. Latin America
8.2.2.6.5.1. Market
Estimation, 2013 – 2018
8.2.2.6.5.2. Market
Forecast, 2019 – 2027
8.2.3. Cryopreservation
Media
8.2.3.1. Definition
8.2.3.2. Market Penetration, 2018
8.2.3.3. Market Estimation, 2013 – 2018
8.2.3.4. Market Forecast, 2019 – 2027
8.2.3.5. Compound Annual Growth Rate (CAGR)
8.2.3.6. Regional Bifurcation
8.2.3.6.1. North America
8.2.3.6.1.1. Market
Estimation, 2013 – 2018
8.2.3.6.1.2. Market
Forecast, 2019 – 2027
8.2.3.6.2. Europe
8.2.3.6.2.1. Market
Estimation, 2013 – 2018
8.2.3.6.2.2. Market
Forecast, 2019 – 2027
8.2.3.6.3. Asia Pacific
8.2.3.6.3.1. Market
Estimation, 2013 – 2018
8.2.3.6.3.2. Market
Forecast, 2019 – 2027
8.2.3.6.4. Middle East and Africa
8.2.3.6.4.1. Market
Estimation, 2013 – 2018
8.2.3.6.4.2. Market
Forecast, 2019 – 2027
8.2.3.6.5. Latin America
8.2.3.6.5.1. Market
Estimation, 2013 – 2018
8.2.3.6.5.2. Market
Forecast, 2019 – 2027
8.2.4. Embryo
Culture Media
8.2.4.1. Definition
8.2.4.2. Market Penetration, 2018
8.2.4.3. Market Estimation, 2013 – 2018
8.2.4.4. Market Forecast, 2019 – 2027
8.2.4.5. Compound Annual Growth Rate (CAGR)
8.2.4.6. Regional Bifurcation
8.2.4.6.1. North America
8.2.4.6.1.1. Market
Estimation, 2013 – 2018
8.2.4.6.1.2. Market
Forecast, 2019 – 2027
8.2.4.6.2. Europe
8.2.4.6.2.1. Market
Estimation, 2013 – 2018
8.2.4.6.2.2. Market
Forecast, 2019 – 2027
8.2.4.6.3. Asia Pacific
8.2.4.6.3.1. Market
Estimation, 2013 – 2018
8.2.4.6.3.2. Market
Forecast, 2019 – 2027
8.2.4.6.4. Middle East and Africa
8.2.4.6.4.1. Market
Estimation, 2013 – 2018
8.2.4.6.4.2. Market
Forecast, 2019 – 2027
8.2.4.6.5. Latin America
8.2.4.6.5.1. Market
Estimation, 2013 – 2018
8.2.4.6.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Reagents
9. Global In-Vitro Fertilization
Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Equipment
9.2.1. Sperm
Separation Systems
9.2.1.1. Definition
9.2.1.2. Market Penetration, 2018
9.2.1.3. Market Estimation, 2013 – 2018
9.2.1.4. Market Forecast, 2019 – 2027
9.2.1.5. Compound Annual Growth Rate (CAGR)
9.2.1.6. Regional Bifurcation
9.2.1.6.1. North America
9.2.1.6.1.1. Market
Estimation, 2013 – 2018
9.2.1.6.1.2. Market
Forecast, 2019 – 2027
9.2.1.6.2. Europe
9.2.1.6.2.1. Market
Estimation, 2013 – 2018
9.2.1.6.2.2. Market
Forecast, 2019 – 2027
9.2.1.6.3. Asia Pacific
9.2.1.6.3.1. Market
Estimation, 2013 – 2018
9.2.1.6.3.2. Market
Forecast, 2019 – 2027
9.2.1.6.4. Middle East and Africa
9.2.1.6.4.1. Market
Estimation, 2013 – 2018
9.2.1.6.4.2. Market
Forecast, 2019 – 2027
9.2.1.6.5. Latin America
9.2.1.6.5.1. Market
Estimation, 2013 – 2018
9.2.1.6.5.2. Market
Forecast, 2019 – 2027
9.2.2. OVUM
Aspiration Pumps
9.2.2.1. Definition
9.2.2.2. Market Penetration, 2018
9.2.2.3. Market Estimation, 2013 – 2018
9.2.2.4. Market Forecast, 2019 – 2027
9.2.2.5. Compound Annual Growth Rate (CAGR)
9.2.2.6. Regional Bifurcation
9.2.2.6.1. North America
9.2.2.6.1.1. Market
Estimation, 2013 – 2018
9.2.2.6.1.2. Market
Forecast, 2019 – 2027
9.2.2.6.2. Europe
9.2.2.6.2.1. Market
Estimation, 2013 – 2018
9.2.2.6.2.2. Market
Forecast, 2019 – 2027
9.2.2.6.3. Asia Pacific
9.2.2.6.3.1. Market
Estimation, 2013 – 2018
9.2.2.6.3.2. Market
Forecast, 2019 – 2027
9.2.2.6.4. Middle East and Africa
9.2.2.6.4.1. Market
Estimation, 2013 – 2018
9.2.2.6.4.2. Market
Forecast, 2019 – 2027
9.2.2.6.5. Latin America
9.2.2.6.5.1. Market
Estimation, 2013 – 2018
9.2.2.6.5.2. Market
Forecast, 2019 – 2027
9.2.3. Cabinets
9.2.3.1. Definition
9.2.3.2. Market Penetration, 2018
9.2.3.3. Market Estimation, 2013 – 2018
9.2.3.4. Market Forecast, 2019 – 2027
9.2.3.5. Compound Annual Growth Rate (CAGR)
9.2.3.6. Regional Bifurcation
9.2.3.6.1. North America
9.2.3.6.1.1. Market
Estimation, 2013 – 2018
9.2.3.6.1.2. Market
Forecast, 2019 – 2027
9.2.3.6.2. Europe
9.2.3.6.2.1. Market
Estimation, 2013 – 2018
9.2.3.6.2.2. Market
Forecast, 2019 – 2027
9.2.3.6.3. Asia Pacific
9.2.3.6.3.1. Market
Estimation, 2013 – 2018
9.2.3.6.3.2. Market
Forecast, 2019 – 2027
9.2.3.6.4. Middle East and Africa
9.2.3.6.4.1. Market
Estimation, 2013 – 2018
9.2.3.6.4.2. Market
Forecast, 2019 – 2027
9.2.3.6.5. Latin America
9.2.3.6.5.1. Market
Estimation, 2013 – 2018
9.2.3.6.5.2. Market
Forecast, 2019 – 2027
9.2.4. Incubators
9.2.4.1. Definition
9.2.4.2. Market Penetration, 2018
9.2.4.3. Market Estimation, 2013 – 2018
9.2.4.4. Market Forecast, 2019 – 2027
9.2.4.5. Compound Annual Growth Rate (CAGR)
9.2.4.6. Regional Bifurcation
9.2.4.6.1. North America
9.2.4.6.1.1. Market
Estimation, 2013 – 2018
9.2.4.6.1.2. Market
Forecast, 2019 – 2027
9.2.4.6.2. Europe
9.2.4.6.2.1. Market
Estimation, 2013 – 2018
9.2.4.6.2.2. Market
Forecast, 2019 – 2027
9.2.4.6.3. Asia Pacific
9.2.4.6.3.1. Market
Estimation, 2013 – 2018
9.2.4.6.3.2. Market
Forecast, 2019 – 2027
9.2.4.6.4. Middle East and Africa
9.2.4.6.4.1. Market
Estimation, 2013 – 2018
9.2.4.6.4.2. Market
Forecast, 2019 – 2027
9.2.4.6.5. Latin America
9.2.4.6.5.1. Market
Estimation, 2013 – 2018
9.2.4.6.5.2. Market
Forecast, 2019 – 2027
9.2.5. Micromanipulator
Systems
9.2.5.1. Definition
9.2.5.2. Market Penetration, 2018
9.2.5.3. Market Estimation, 2013 – 2018
9.2.5.4. Market Forecast, 2019 – 2027
9.2.5.5. Compound Annual Growth Rate (CAGR)
9.2.5.6. Regional Bifurcation
9.2.5.6.1. North America
9.2.5.6.1.1. Market
Estimation, 2013 – 2018
9.2.5.6.1.2. Market
Forecast, 2019 – 2027
9.2.5.6.2. Europe
9.2.5.6.2.1. Market
Estimation, 2013 – 2018
9.2.5.6.2.2. Market
Forecast, 2019 – 2027
9.2.5.6.3. Asia Pacific
9.2.5.6.3.1. Market
Estimation, 2013 – 2018
9.2.5.6.3.2. Market
Forecast, 2019 – 2027
9.2.5.6.4. Middle East and Africa
9.2.5.6.4.1. Market
Estimation, 2013 – 2018
9.2.5.6.4.2. Market
Forecast, 2019 – 2027
9.2.5.6.5. Latin America
9.2.5.6.5.1. Market
Estimation, 2013 – 2018
9.2.5.6.5.2. Market
Forecast, 2019 – 2027
9.2.6. Gas
Analyzers
9.2.6.1. Definition
9.2.6.2. Market Penetration, 2018
9.2.6.3. Market Estimation, 2013 – 2018
9.2.6.4. Market Forecast, 2019 – 2027
9.2.6.5. Compound Annual Growth Rate (CAGR)
9.2.6.6. Regional Bifurcation
9.2.6.6.1. North America
9.2.6.6.1.1. Market
Estimation, 2013 – 2018
9.2.6.6.1.2. Market
Forecast, 2019 – 2027
9.2.6.6.2. Europe
9.2.6.6.2.1. Market
Estimation, 2013 – 2018
9.2.6.6.2.2. Market
Forecast, 2019 – 2027
9.2.6.6.3. Asia Pacific
9.2.6.6.3.1. Market
Estimation, 2013 – 2018
9.2.6.6.3.2. Market
Forecast, 2019 – 2027
9.2.6.6.4. Middle East and Africa
9.2.6.6.4.1. Market
Estimation, 2013 – 2018
9.2.6.6.4.2. Market
Forecast, 2019 – 2027
9.2.6.6.5. Latin America
9.2.6.6.5.1. Market
Estimation, 2013 – 2018
9.2.6.6.5.2. Market
Forecast, 2019 – 2027
9.2.7. Cryosystems
9.2.7.1. Definition
9.2.7.2. Market Penetration, 2018
9.2.7.3. Market Estimation, 2013 – 2018
9.2.7.4. Market Forecast, 2019 – 2027
9.2.7.5. Compound Annual Growth Rate (CAGR)
9.2.7.6. Regional Bifurcation
9.2.7.6.1. North America
9.2.7.6.1.1. Market
Estimation, 2013 – 2018
9.2.7.6.1.2. Market
Forecast, 2019 – 2027
9.2.7.6.2. Europe
9.2.7.6.2.1. Market
Estimation, 2013 – 2018
9.2.7.6.2.2. Market
Forecast, 2019 – 2027
9.2.7.6.3. Asia Pacific
9.2.7.6.3.1. Market
Estimation, 2013 – 2018
9.2.7.6.3.2. Market
Forecast, 2019 – 2027
9.2.7.6.4. Middle East and Africa
9.2.7.6.4.1. Market
Estimation, 2013 – 2018
9.2.7.6.4.2. Market
Forecast, 2019 – 2027
9.2.7.6.5. Latin America
9.2.7.6.5.1. Market
Estimation, 2013 – 2018
9.2.7.6.5.2. Market
Forecast, 2019 – 2027
9.2.8. Others
9.2.8.1. Definition
9.2.8.2. Market Penetration, 2018
9.2.8.3. Market Estimation, 2013 – 2018
9.2.8.4. Market Forecast, 2019 – 2027
9.2.8.5. Compound Annual Growth Rate (CAGR)
9.2.8.6. Regional Bifurcation
9.2.8.6.1. North America
9.2.8.6.1.1. Market
Estimation, 2013 – 2018
9.2.8.6.1.2. Market
Forecast, 2019 – 2027
9.2.8.6.2. Europe
9.2.8.6.2.1. Market
Estimation, 2013 – 2018
9.2.8.6.2.2. Market
Forecast, 2019 – 2027
9.2.8.6.3. Asia Pacific
9.2.8.6.3.1. Market
Estimation, 2013 – 2018
9.2.8.6.3.2. Market
Forecast, 2019 – 2027
9.2.8.6.4. Middle East and Africa
9.2.8.6.4.1. Market
Estimation, 2013 – 2018
9.2.8.6.4.2. Market
Forecast, 2019 – 2027
9.2.8.6.5. Latin America
9.2.8.6.5.1. Market
Estimation, 2013 – 2018
9.2.8.6.5.2. Market
Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By
Equipment
10. Global In-Vitro Fertilization
Market Analysis and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By End Use
10.2.1. Fertility
centers
10.2.1.1. Definition
10.2.1.2. Market Penetration, 2018
10.2.1.3. Market Estimation, 2013 – 2018
10.2.1.4. Market Forecast, 2019 – 2027
10.2.1.5. Compound Annual Growth Rate (CAGR)
10.2.1.6. Regional Bifurcation
10.2.1.6.1. North America
10.2.1.6.1.1. Market
Estimation, 2013 – 2018
10.2.1.6.1.2. Market
Forecast, 2019 – 2027
10.2.1.6.2. Europe
10.2.1.6.2.1. Market
Estimation, 2013 – 2018
10.2.1.6.2.2. Market
Forecast, 2019 – 2027
10.2.1.6.3. Asia Pacific
10.2.1.6.3.1. Market
Estimation, 2013 – 2018
10.2.1.6.3.2. Market
Forecast, 2019 – 2027
10.2.1.6.4. Middle East and Africa
10.2.1.6.4.1. Market
Estimation, 2013 – 2018
10.2.1.6.4.2. Market
Forecast, 2019 – 2027
10.2.1.6.5. Latin America
10.2.1.6.5.1. Market
Estimation, 2013 – 2018
10.2.1.6.5.2. Market
Forecast, 2019 – 2027
10.2.2. Hospitals
10.2.2.1. Definition
10.2.2.2. Market Penetration, 2018
10.2.2.3. Market Estimation, 2013 – 2018
10.2.2.4. Market Forecast, 2019 – 2027
10.2.2.5. Compound Annual Growth Rate (CAGR)
10.2.2.6. Regional Bifurcation
10.2.2.6.1. North America
10.2.2.6.1.1. Market
Estimation, 2013 – 2018
10.2.2.6.1.2. Market
Forecast, 2019 – 2027
10.2.2.6.2. Europe
10.2.2.6.2.1. Market
Estimation, 2013 – 2018
10.2.2.6.2.2. Market
Forecast, 2019 – 2027
10.2.2.6.3. Asia Pacific
10.2.2.6.3.1. Market
Estimation, 2013 – 2018
10.2.2.6.3.2. Market
Forecast, 2019 – 2027
10.2.2.6.4. Middle East and Africa
10.2.2.6.4.1. Market
Estimation, 2013 – 2018
10.2.2.6.4.2. Market
Forecast, 2019 – 2027
10.2.2.6.5. Latin America
10.2.2.6.5.1. Market
Estimation, 2013 – 2018
10.2.2.6.5.2. Market
Forecast, 2019 – 2027
10.2.3. Cryobanks
10.2.3.1. Definition
10.2.3.2. Market Penetration, 2018
10.2.3.3. Market Estimation, 2013 – 2018
10.2.3.4. Market Forecast, 2019 – 2027
10.2.3.5. Compound Annual Growth Rate (CAGR)
10.2.3.6. Regional Bifurcation
10.2.3.6.1. North America
10.2.3.6.1.1. Market
Estimation, 2013 – 2018
10.2.3.6.1.2. Market
Forecast, 2019 – 2027
10.2.3.6.2. Europe
10.2.3.6.2.1. Market
Estimation, 2013 – 2018
10.2.3.6.2.2. Market
Forecast, 2019 – 2027
10.2.3.6.3. Asia Pacific
10.2.3.6.3.1. Market
Estimation, 2013 – 2018
10.2.3.6.3.2. Market
Forecast, 2019 – 2027
10.2.3.6.4. Middle East and Africa
10.2.3.6.4.1. Market
Estimation, 2013 – 2018
10.2.3.6.4.2. Market
Forecast, 2019 – 2027
10.2.3.6.5. Latin America
10.2.3.6.5.1. Market
Estimation, 2013 – 2018
10.2.3.6.5.2. Market
Forecast, 2019 – 2027
10.2.4. Research
Laboratories
10.2.4.1. Definition
10.2.4.2. Market Penetration, 2018
10.2.4.3. Market Estimation, 2013 – 2018
10.2.4.4. Market Forecast, 2019 – 2027
10.2.4.5. Compound Annual Growth Rate (CAGR)
10.2.4.6. Regional Bifurcation
10.2.4.6.1. North America
10.2.4.6.1.1. Market
Estimation, 2013 – 2018
10.2.4.6.1.2. Market
Forecast, 2019 – 2027
10.2.4.6.2. Europe
10.2.4.6.2.1. Market
Estimation, 2013 – 2018
10.2.4.6.2.2. Market
Forecast, 2019 – 2027
10.2.4.6.3. Asia Pacific
10.2.4.6.3.1. Market
Estimation, 2013 – 2018
10.2.4.6.3.2. Market
Forecast, 2019 – 2027
10.2.4.6.4. Middle East and Africa
10.2.4.6.4.1. Market
Estimation, 2013 – 2018
10.2.4.6.4.2. Market
Forecast, 2019 – 2027
10.2.4.6.5. Latin America
10.2.4.6.5.1. Market
Estimation, 2013 – 2018
10.2.4.6.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By End
Use
11. North America In-Vitro Fertilization Market Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. North
America In-Vitro Fertilization Market
Revenue (US$ Mn)
11.2. North
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Reagents
11.2.1. OVUM
Processing Media
11.2.2. Sperm
Processing Media
11.2.3. Cryopreservation
Media
11.2.4. Embryo
Culture Media
11.3. North
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Equipment
11.3.1. Sperm
Separation Systems
11.3.2. OVUM
Aspiration Pumps
11.3.3. Cabinets
11.3.4. Incubators
11.3.5. Micromanipulator
Systems
11.3.6. Gas
Analyzers
11.3.7. Cryosystems
11.3.8. Others
11.4. North
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By End Use
11.4.1. Fertility
centers
11.4.2. Hospitals
11.4.3. Cryobanks
11.4.4. Research
Laboratories
11.5. North
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
11.5.1.1.1. OVUM Processing Media
11.5.1.1.2. Sperm Processing Media
11.5.1.1.3. Cryopreservation Media
11.5.1.1.4. Embryo Culture Media
11.5.1.2. U.S In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
11.5.1.2.1. Sperm Separation Systems
11.5.1.2.2. OVUM Aspiration Pumps
11.5.1.2.3. Cabinets
11.5.1.2.4. Incubators
11.5.1.2.5. Micromanipulator Systems
11.5.1.2.6. Gas Analyzers
11.5.1.2.7. Cryosystems
11.5.1.2.8. Others
11.5.1.3. U.S In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
11.5.1.3.1. Fertility centers
11.5.1.3.2. Hospitals
11.5.1.3.3. Cryobanks
11.5.1.3.4. Research Laboratories
11.5.2. Canada
11.5.2.1. Canada In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
11.5.2.1.1. OVUM Processing Media
11.5.2.1.2. Sperm Processing Media
11.5.2.1.3. Cryopreservation Media
11.5.2.1.4. Embryo Culture Media
11.5.2.2. Canada In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
11.5.2.2.1. Sperm Separation Systems
11.5.2.2.2. OVUM Aspiration Pumps
11.5.2.2.3. Cabinets
11.5.2.2.4. Incubators
11.5.2.2.5. Micromanipulator Systems
11.5.2.2.6. Gas Analyzers
11.5.2.2.7. Cryosystems
11.5.2.2.8. Others
11.5.2.3. Canada In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
11.5.2.3.1. Fertility centers
11.5.2.3.2. Hospitals
11.5.2.3.3. Cryobanks
11.5.2.3.4. Research Laboratories
11.5.3. Mexico
11.5.3.1. Mexico In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
11.5.3.1.1. OVUM Processing Media
11.5.3.1.2. Sperm Processing Media
11.5.3.1.3. Cryopreservation Media
11.5.3.1.4. Embryo Culture Media
11.5.3.2. Mexico In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
11.5.3.2.1. Sperm Separation Systems
11.5.3.2.2. OVUM Aspiration Pumps
11.5.3.2.3. Cabinets
11.5.3.2.4. Incubators
11.5.3.2.5. Micromanipulator Systems
11.5.3.2.6. Gas Analyzers
11.5.3.2.7. Cryosystems
11.5.3.2.8. Others
11.5.3.3. Mexico In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
11.5.3.3.1. Fertility centers
11.5.3.3.2. Hospitals
11.5.3.3.3. Cryobanks
11.5.3.3.4. Research Laboratories
11.5.4. Rest of
North America
11.5.4.1. Rest of North America In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
11.5.4.1.1. OVUM Processing Media
11.5.4.1.2. Sperm Processing Media
11.5.4.1.3. Cryopreservation Media
11.5.4.1.4. Embryo Culture Media
11.5.4.2. Rest of North America In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
11.5.4.2.1. Sperm Separation Systems
11.5.4.2.2. OVUM Aspiration Pumps
11.5.4.2.3. Cabinets
11.5.4.2.4. Incubators
11.5.4.2.5. Micromanipulator Systems
11.5.4.2.6. Gas Analyzers
11.5.4.2.7. Cryosystems
11.5.4.2.8. Others
11.5.4.3. Rest of North America In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
11.5.4.3.1. Fertility centers
11.5.4.3.2. Hospitals
11.5.4.3.3. Cryobanks
11.5.4.3.4. Research Laboratories
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Reagents
11.6.3. By
Equipment
11.6.4. By End
Use
12. Europe In-Vitro Fertilization
Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Europe
In-Vitro Fertilization Market Revenue
(US$ Mn)
12.2. Europe
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Reagents
12.2.1. OVUM
Processing Media
12.2.2. Sperm
Processing Media
12.2.3. Cryopreservation
Media
12.2.4. Embryo
Culture Media
12.3. Europe
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Equipment
12.3.1. Sperm
Separation Systems
12.3.2. OVUM
Aspiration Pumps
12.3.3. Cabinets
12.3.4. Incubators
12.3.5. Micromanipulator
Systems
12.3.6. Gas
Analyzers
12.3.7. Cryosystems
12.3.8. Others
12.4. Europe
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By End Use
12.4.1. Fertility
centers
12.4.2. Hospitals
12.4.3. Cryobanks
12.4.4. Research
Laboratories
12.5. Europe
In-Vitro Fertilization Market Revenue
(US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
12.5.1.1.1. OVUM Processing Media
12.5.1.1.2. Sperm Processing Media
12.5.1.1.3. Cryopreservation Media
12.5.1.1.4. Embryo Culture Media
12.5.1.2. France In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
12.5.1.2.1. Sperm Separation Systems
12.5.1.2.2. OVUM Aspiration Pumps
12.5.1.2.3. Cabinets
12.5.1.2.4. Incubators
12.5.1.2.5. Micromanipulator Systems
12.5.1.2.6. Gas Analyzers
12.5.1.2.7. Cryosystems
12.5.1.2.8. Others
12.5.1.3. France In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
12.5.1.3.1. Fertility centers
12.5.1.3.2. Hospitals
12.5.1.3.3. Cryobanks
12.5.1.3.4. Research Laboratories
12.5.2. The UK
12.5.2.1. The UK In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
12.5.2.1.1. OVUM Processing Media
12.5.2.1.2. Sperm Processing Media
12.5.2.1.3. Cryopreservation Media
12.5.2.1.4. Embryo Culture Media
12.5.2.2. The UK In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
12.5.2.2.1. Sperm Separation Systems
12.5.2.2.2. OVUM Aspiration Pumps
12.5.2.2.3. Cabinets
12.5.2.2.4. Incubators
12.5.2.2.5. Micromanipulator Systems
12.5.2.2.6. Gas Analyzers
12.5.2.2.7. Cryosystems
12.5.2.2.8. Others
12.5.2.3. The UK In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
12.5.2.3.1. Fertility centers
12.5.2.3.2. Hospitals
12.5.2.3.3. Cryobanks
12.5.2.3.4. Research Laboratories
12.5.3. Spain
12.5.3.1. Spain In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
12.5.3.1.1. OVUM Processing Media
12.5.3.1.2. Sperm Processing Media
12.5.3.1.3. Cryopreservation Media
12.5.3.1.4. Embryo Culture Media
12.5.3.2. Spain In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
12.5.3.2.1. Sperm Separation Systems
12.5.3.2.2. OVUM Aspiration Pumps
12.5.3.2.3. Cabinets
12.5.3.2.4. Incubators
12.5.3.2.5. Micromanipulator Systems
12.5.3.2.6. Gas Analyzers
12.5.3.2.7. Cryosystems
12.5.3.2.8. Others
12.5.3.3. Spain In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
12.5.3.3.1. Fertility centers
12.5.3.3.2. Hospitals
12.5.3.3.3. Cryobanks
12.5.3.3.4. Research Laboratories
12.5.4. Germany
12.5.4.1. Germany In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
12.5.4.1.1. OVUM Processing Media
12.5.4.1.2. Sperm Processing Media
12.5.4.1.3. Cryopreservation Media
12.5.4.1.4. Embryo Culture Media
12.5.4.2. Germany In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
12.5.4.2.1. Sperm Separation Systems
12.5.4.2.2. OVUM Aspiration Pumps
12.5.4.2.3. Cabinets
12.5.4.2.4. Incubators
12.5.4.2.5. Micromanipulator Systems
12.5.4.2.6. Gas Analyzers
12.5.4.2.7. Cryosystems
12.5.4.2.8. Others
12.5.4.3. Germany In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
12.5.4.3.1. Fertility centers
12.5.4.3.2. Hospitals
12.5.4.3.3. Cryobanks
12.5.4.3.4. Research Laboratories
12.5.5. Italy
12.5.5.1. Italy In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
12.5.5.1.1. OVUM Processing Media
12.5.5.1.2. Sperm Processing Media
12.5.5.1.3. Cryopreservation Media
12.5.5.1.4. Embryo Culture Media
12.5.5.2. Italy In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
12.5.5.2.1. Sperm Separation Systems
12.5.5.2.2. OVUM Aspiration Pumps
12.5.5.2.3. Cabinets
12.5.5.2.4. Incubators
12.5.5.2.5. Micromanipulator Systems
12.5.5.2.6. Gas Analyzers
12.5.5.2.7. Cryosystems
12.5.5.2.8. Others
12.5.5.3. Italy In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
12.5.5.3.1. Fertility centers
12.5.5.3.2. Hospitals
12.5.5.3.3. Cryobanks
12.5.5.3.4. Research Laboratories
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
12.5.6.1.1. OVUM Processing Media
12.5.6.1.2. Sperm Processing Media
12.5.6.1.3. Cryopreservation Media
12.5.6.1.4. Embryo Culture Media
12.5.6.2. Nordic Countries In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
12.5.6.2.1. Sperm Separation Systems
12.5.6.2.2. OVUM Aspiration Pumps
12.5.6.2.3. Cabinets
12.5.6.2.4. Incubators
12.5.6.2.5. Micromanipulator Systems
12.5.6.2.6. Gas Analyzers
12.5.6.2.7. Cryosystems
12.5.6.2.8. Others
12.5.6.3. Nordic Countries In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
12.5.6.3.1. Fertility centers
12.5.6.3.2. Hospitals
12.5.6.3.3. Cryobanks
12.5.6.3.4. Research Laboratories
12.5.6.4. Nordic Countries In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
12.5.7.1.1. OVUM Processing Media
12.5.7.1.2. Sperm Processing Media
12.5.7.1.3. Cryopreservation Media
12.5.7.1.4. Embryo Culture Media
12.5.7.2. Benelux Union In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
12.5.7.2.1. Sperm Separation Systems
12.5.7.2.2. OVUM Aspiration Pumps
12.5.7.2.3. Cabinets
12.5.7.2.4. Incubators
12.5.7.2.5. Micromanipulator Systems
12.5.7.2.6. Gas Analyzers
12.5.7.2.7. Cryosystems
12.5.7.2.8. Others
12.5.7.3. Benelux Union In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
12.5.7.3.1. Fertility centers
12.5.7.3.2. Hospitals
12.5.7.3.3. Cryobanks
12.5.7.3.4. Research Laboratories
12.5.7.4. Benelux Union In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
12.5.8.1.1. OVUM Processing Media
12.5.8.1.2. Sperm Processing Media
12.5.8.1.3. Cryopreservation Media
12.5.8.1.4. Embryo Culture Media
12.5.8.2. Rest of Europe In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
12.5.8.2.1. Sperm Separation Systems
12.5.8.2.2. OVUM Aspiration Pumps
12.5.8.2.3. Cabinets
12.5.8.2.4. Incubators
12.5.8.2.5. Micromanipulator Systems
12.5.8.2.6. Gas Analyzers
12.5.8.2.7. Cryosystems
12.5.8.2.8. Others
12.5.8.3. Rest of Europe In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
12.5.8.3.1. Fertility centers
12.5.8.3.2. Hospitals
12.5.8.3.3. Cryobanks
12.5.8.3.4. Research Laboratories
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Reagents
12.6.3. By
Equipment
12.6.4. By End
Use
13. Asia Pacific In-Vitro Fertilization Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Asia
Pacific In-Vitro Fertilization Market
Revenue (US$ Mn)
13.2. Asia
Pacific In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Reagents
13.2.1. OVUM
Processing Media
13.2.2. Sperm
Processing Media
13.2.3. Cryopreservation
Media
13.2.4. Embryo
Culture Media
13.3. Asia
Pacific In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Equipment
13.3.1. Sperm
Separation Systems
13.3.2. OVUM
Aspiration Pumps
13.3.3. Cabinets
13.3.4. Incubators
13.3.5. Micromanipulator
Systems
13.3.6. Gas
Analyzers
13.3.7. Cryosystems
13.3.8. Others
13.4. Asia
Pacific In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By End Use
13.4.1. Fertility
centers
13.4.2. Hospitals
13.4.3. Cryobanks
13.4.4. Research
Laboratories
13.5. Asia
Pacific In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
13.5.1.1.1. OVUM Processing Media
13.5.1.1.2. Sperm Processing Media
13.5.1.1.3. Cryopreservation Media
13.5.1.1.4. Embryo Culture Media
13.5.1.2. China In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
13.5.1.2.1. Sperm Separation Systems
13.5.1.2.2. OVUM Aspiration Pumps
13.5.1.2.3. Cabinets
13.5.1.2.4. Incubators
13.5.1.2.5. Micromanipulator Systems
13.5.1.2.6. Gas Analyzers
13.5.1.2.7. Cryosystems
13.5.1.2.8. Others
13.5.1.3. China In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
13.5.1.3.1. Fertility centers
13.5.1.3.2. Hospitals
13.5.1.3.3. Cryobanks
13.5.1.3.4. Research Laboratories
13.5.2. Japan
13.5.2.1. Japan In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
13.5.2.1.1. OVUM Processing Media
13.5.2.1.2. Sperm Processing Media
13.5.2.1.3. Cryopreservation Media
13.5.2.1.4. Embryo Culture Media
13.5.2.2. Japan In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
13.5.2.2.1. Sperm Separation Systems
13.5.2.2.2. OVUM Aspiration Pumps
13.5.2.2.3. Cabinets
13.5.2.2.4. Incubators
13.5.2.2.5. Micromanipulator Systems
13.5.2.2.6. Gas Analyzers
13.5.2.2.7. Cryosystems
13.5.2.2.8. Others
13.5.2.3. Japan In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
13.5.2.3.1. Fertility centers
13.5.2.3.2. Hospitals
13.5.2.3.3. Cryobanks
13.5.2.3.4. Research Laboratories
13.5.3. India
13.5.3.1. India In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
13.5.3.1.1. OVUM Processing Media
13.5.3.1.2. Sperm Processing Media
13.5.3.1.3. Cryopreservation Media
13.5.3.1.4. Embryo Culture Media
13.5.3.2. India In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
13.5.3.2.1. Sperm Separation Systems
13.5.3.2.2. OVUM Aspiration Pumps
13.5.3.2.3. Cabinets
13.5.3.2.4. Incubators
13.5.3.2.5. Micromanipulator Systems
13.5.3.2.6. Gas Analyzers
13.5.3.2.7. Cryosystems
13.5.3.2.8. Others
13.5.3.3. India In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
13.5.3.3.1. Fertility centers
13.5.3.3.2. Hospitals
13.5.3.3.3. Cryobanks
13.5.3.3.4. Research Laboratories
13.5.4. New
Zealand
13.5.4.1. New Zealand In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
13.5.4.1.1. OVUM Processing Media
13.5.4.1.2. Sperm Processing Media
13.5.4.1.3. Cryopreservation Media
13.5.4.1.4. Embryo Culture Media
13.5.4.2. New Zealand In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
13.5.4.2.1. Sperm Separation Systems
13.5.4.2.2. OVUM Aspiration Pumps
13.5.4.2.3. Cabinets
13.5.4.2.4. Incubators
13.5.4.2.5. Micromanipulator Systems
13.5.4.2.6. Gas Analyzers
13.5.4.2.7. Cryosystems
13.5.4.2.8. Others
13.5.4.3. New Zealand In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
13.5.4.3.1. Fertility centers
13.5.4.3.2. Hospitals
13.5.4.3.3. Cryobanks
13.5.4.3.4. Research Laboratories
13.5.5. Australia
13.5.5.1. Australia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
13.5.5.1.1. OVUM Processing Media
13.5.5.1.2. Sperm Processing Media
13.5.5.1.3. Cryopreservation Media
13.5.5.1.4. Embryo Culture Media
13.5.5.2. Australia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
13.5.5.2.1. Sperm Separation Systems
13.5.5.2.2. OVUM Aspiration Pumps
13.5.5.2.3. Cabinets
13.5.5.2.4. Incubators
13.5.5.2.5. Micromanipulator Systems
13.5.5.2.6. Gas Analyzers
13.5.5.2.7. Cryosystems
13.5.5.2.8. Others
13.5.5.3. Australia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
13.5.5.3.1. Fertility centers
13.5.5.3.2. Hospitals
13.5.5.3.3. Cryobanks
13.5.5.3.4. Research Laboratories
13.5.6. South
Korea
13.5.6.1. South Korea In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Reagents
13.5.6.1.1. OVUM Processing Media
13.5.6.1.2. Sperm Processing Media
13.5.6.1.3. Cryopreservation Media
13.5.6.1.4. Embryo Culture Media
13.5.6.2. South Korea In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
13.5.6.2.1. Sperm Separation Systems
13.5.6.2.2. OVUM Aspiration Pumps
13.5.6.2.3. Cabinets
13.5.6.2.4. Incubators
13.5.6.2.5. Micromanipulator Systems
13.5.6.2.6. Gas Analyzers
13.5.6.2.7. Cryosystems
13.5.6.2.8. Others
13.5.6.3. South Korea In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
13.5.6.3.1. Fertility centers
13.5.6.3.2. Hospitals
13.5.6.3.3. Cryobanks
13.5.6.3.4. Research Laboratories
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
13.5.7.1.1. OVUM Processing Media
13.5.7.1.2. Sperm Processing Media
13.5.7.1.3. Cryopreservation Media
13.5.7.1.4. Embryo Culture Media
13.5.7.2. Southeast Asia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
13.5.7.2.1. Sperm Separation Systems
13.5.7.2.2. OVUM Aspiration Pumps
13.5.7.2.3. Cabinets
13.5.7.2.4. Incubators
13.5.7.2.5. Micromanipulator Systems
13.5.7.2.6. Gas Analyzers
13.5.7.2.7. Cryosystems
13.5.7.2.8. Others
13.5.7.3. Southeast Asia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
13.5.7.3.1. Fertility centers
13.5.7.3.2. Hospitals
13.5.7.3.3. Cryobanks
13.5.7.3.4. Research Laboratories
13.5.7.4. Southeast Asia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
13.5.8.1.1. OVUM Processing Media
13.5.8.1.2. Sperm Processing Media
13.5.8.1.3. Cryopreservation Media
13.5.8.1.4. Embryo Culture Media
13.5.8.2. Rest of Asia Pacific In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
13.5.8.2.1. Sperm Separation Systems
13.5.8.2.2. OVUM Aspiration Pumps
13.5.8.2.3. Cabinets
13.5.8.2.4. Incubators
13.5.8.2.5. Micromanipulator Systems
13.5.8.2.6. Gas Analyzers
13.5.8.2.7. Cryosystems
13.5.8.2.8. Others
13.5.8.3. Rest of Asia Pacific In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
13.5.8.3.1. Fertility centers
13.5.8.3.2. Hospitals
13.5.8.3.3. Cryobanks
13.5.8.3.4. Research Laboratories
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Reagents
13.6.3. By
Equipment
13.6.4. By End
Use
14. Middle East and Africa In-Vitro Fertilization Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Middle
East and Africa In-Vitro Fertilization
Market Revenue (US$ Mn)
14.2. Middle
East and Africa In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
14.2.1. OVUM
Processing Media
14.2.2. Sperm
Processing Media
14.2.3. Cryopreservation
Media
14.2.4. Embryo
Culture Media
14.3. Middle
East and Africa In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
14.3.1. Sperm
Separation Systems
14.3.2. OVUM
Aspiration Pumps
14.3.3. Cabinets
14.3.4. Incubators
14.3.5. Micromanipulator
Systems
14.3.6. Gas
Analyzers
14.3.7. Cryosystems
14.3.8. Others
14.4. Middle
East and Africa In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
14.4.1. Fertility
centers
14.4.2. Hospitals
14.4.3. Cryobanks
14.4.4. Research
Laboratories
14.5. Middle
East and Africa In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
14.5.1.1.1. OVUM Processing Media
14.5.1.1.2. Sperm Processing Media
14.5.1.1.3. Cryopreservation Media
14.5.1.1.4. Embryo Culture Media
14.5.1.2. Saudi Arabia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Equipment
14.5.1.2.1. Sperm Separation Systems
14.5.1.2.2. OVUM Aspiration Pumps
14.5.1.2.3. Cabinets
14.5.1.2.4. Incubators
14.5.1.2.5. Micromanipulator Systems
14.5.1.2.6. Gas Analyzers
14.5.1.2.7. Cryosystems
14.5.1.2.8. Others
14.5.1.3. Saudi Arabia In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
14.5.1.3.1. Fertility centers
14.5.1.3.2. Hospitals
14.5.1.3.3. Cryobanks
14.5.1.3.4. Research Laboratories
14.5.2. UAE
14.5.2.1. UAE In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
14.5.2.1.1. OVUM Processing Media
14.5.2.1.2. Sperm Processing Media
14.5.2.1.3. Cryopreservation Media
14.5.2.1.4. Embryo Culture Media
14.5.2.2. UAE In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
14.5.2.2.1. Sperm Separation Systems
14.5.2.2.2. OVUM Aspiration Pumps
14.5.2.2.3. Cabinets
14.5.2.2.4. Incubators
14.5.2.2.5. Micromanipulator Systems
14.5.2.2.6. Gas Analyzers
14.5.2.2.7. Cryosystems
14.5.2.2.8. Others
14.5.2.3. UAE In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
14.5.2.3.1. Fertility centers
14.5.2.3.2. Hospitals
14.5.2.3.3. Cryobanks
14.5.2.3.4. Research Laboratories
14.5.3. Egypt
14.5.3.1. Egypt In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
14.5.3.1.1. OVUM Processing Media
14.5.3.1.2. Sperm Processing Media
14.5.3.1.3. Cryopreservation Media
14.5.3.1.4. Embryo Culture Media
14.5.3.2. Egypt In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
14.5.3.2.1. Sperm Separation Systems
14.5.3.2.2. OVUM Aspiration Pumps
14.5.3.2.3. Cabinets
14.5.3.2.4. Incubators
14.5.3.2.5. Micromanipulator Systems
14.5.3.2.6. Gas Analyzers
14.5.3.2.7. Cryosystems
14.5.3.2.8. Others
14.5.3.3. Egypt In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
14.5.3.3.1. Fertility centers
14.5.3.3.2. Hospitals
14.5.3.3.3. Cryobanks
14.5.3.3.4. Research Laboratories
14.5.4. Kuwait
14.5.4.1. Kuwait In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
14.5.4.1.1. OVUM Processing Media
14.5.4.1.2. Sperm Processing Media
14.5.4.1.3. Cryopreservation Media
14.5.4.1.4. Embryo Culture Media
14.5.4.2. Kuwait In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
14.5.4.2.1. Sperm Separation Systems
14.5.4.2.2. OVUM Aspiration Pumps
14.5.4.2.3. Cabinets
14.5.4.2.4. Incubators
14.5.4.2.5. Micromanipulator Systems
14.5.4.2.6. Gas Analyzers
14.5.4.2.7. Cryosystems
14.5.4.2.8. Others
14.5.4.3. Kuwait In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
14.5.4.3.1. Fertility centers
14.5.4.3.2. Hospitals
14.5.4.3.3. Cryobanks
14.5.4.3.4. Research Laboratories
14.5.5. South
Africa
14.5.5.1. South Africa In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
14.5.5.1.1. OVUM Processing Media
14.5.5.1.2. Sperm Processing Media
14.5.5.1.3. Cryopreservation Media
14.5.5.1.4. Embryo Culture Media
14.5.5.2. South Africa In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
14.5.5.2.1. Sperm Separation Systems
14.5.5.2.2. OVUM Aspiration Pumps
14.5.5.2.3. Cabinets
14.5.5.2.4. Incubators
14.5.5.2.5. Micromanipulator Systems
14.5.5.2.6. Gas Analyzers
14.5.5.2.7. Cryosystems
14.5.5.2.8. Others
14.5.5.3. South Africa In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
14.5.5.3.1. Fertility centers
14.5.5.3.2. Hospitals
14.5.5.3.3. Cryobanks
14.5.5.3.4. Research Laboratories
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
14.5.6.1.1. OVUM Processing Media
14.5.6.1.2. Sperm Processing Media
14.5.6.1.3. Cryopreservation Media
14.5.6.1.4. Embryo Culture Media
14.5.6.2. Rest of Middle East & Africa In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
14.5.6.2.1. Sperm Separation Systems
14.5.6.2.2. OVUM Aspiration Pumps
14.5.6.2.3. Cabinets
14.5.6.2.4. Incubators
14.5.6.2.5. Micromanipulator Systems
14.5.6.2.6. Gas Analyzers
14.5.6.2.7. Cryosystems
14.5.6.2.8. Others
14.5.6.3. Rest of Middle East & Africa In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
14.5.6.3.1. Fertility centers
14.5.6.3.2. Hospitals
14.5.6.3.3. Cryobanks
14.5.6.3.4. Research Laboratories
14.6. Key
Segment for Channeling Investments
14.6.1. By Country
14.6.2. By
Reagents
14.6.3. By
Equipment
14.6.4. By End
Use
15. Latin America In-Vitro Fertilization Market Analysis and Forecasts, 2019 - 2027
15.1. Overview
15.1.1. Latin
America In-Vitro Fertilization Market
Revenue (US$ Mn)
15.2. Latin
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Reagents
15.2.1. OVUM
Processing Media
15.2.2. Sperm
Processing Media
15.2.3. Cryopreservation
Media
15.2.4. Embryo
Culture Media
15.3. Latin
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Equipment
15.3.1. Sperm
Separation Systems
15.3.2. OVUM
Aspiration Pumps
15.3.3. Cabinets
15.3.4. Incubators
15.3.5. Micromanipulator
Systems
15.3.6. Gas
Analyzers
15.3.7. Cryosystems
15.3.8. Others
15.4. Latin
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By End Use
15.4.1. Fertility
centers
15.4.2. Hospitals
15.4.3. Cryobanks
15.4.4. Research
Laboratories
15.5. Latin
America In-Vitro Fertilization Market
Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Reagents
15.5.1.1.1. OVUM Processing Media
15.5.1.1.2. Sperm Processing Media
15.5.1.1.3. Cryopreservation Media
15.5.1.1.4. Embryo Culture Media
15.5.1.2. Brazil In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By Equipment
15.5.1.2.1. Sperm Separation Systems
15.5.1.2.2. OVUM Aspiration Pumps
15.5.1.2.3. Cabinets
15.5.1.2.4. Incubators
15.5.1.2.5. Micromanipulator Systems
15.5.1.2.6. Gas Analyzers
15.5.1.2.7. Cryosystems
15.5.1.2.8. Others
15.5.1.3. Brazil In-Vitro Fertilization
Market Revenue (US$ Mn) and Forecasts, By End Use
15.5.1.3.1. Fertility centers
15.5.1.3.2. Hospitals
15.5.1.3.3. Cryobanks
15.5.1.3.4. Research Laboratories
15.5.2. Argentina
15.5.2.1. Argentina In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Reagents
15.5.2.1.1. OVUM Processing Media
15.5.2.1.2. Sperm Processing Media
15.5.2.1.3. Cryopreservation Media
15.5.2.1.4. Embryo Culture Media
15.5.2.2. Argentina In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
15.5.2.2.1. Sperm Separation Systems
15.5.2.2.2. OVUM Aspiration Pumps
15.5.2.2.3. Cabinets
15.5.2.2.4. Incubators
15.5.2.2.5. Micromanipulator Systems
15.5.2.2.6. Gas Analyzers
15.5.2.2.7. Cryosystems
15.5.2.2.8. Others
15.5.2.3. Argentina In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
15.5.2.3.1. Fertility centers
15.5.2.3.2. Hospitals
15.5.2.3.3. Cryobanks
15.5.2.3.4. Research Laboratories
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By Reagents
15.5.3.1.1. OVUM Processing Media
15.5.3.1.2. Sperm Processing Media
15.5.3.1.3. Cryopreservation Media
15.5.3.1.4. Embryo Culture Media
15.5.3.2. Rest of Latin America In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By
Equipment
15.5.3.2.1. Sperm Separation Systems
15.5.3.2.2. OVUM Aspiration Pumps
15.5.3.2.3. Cabinets
15.5.3.2.4. Incubators
15.5.3.2.5. Micromanipulator Systems
15.5.3.2.6. Gas Analyzers
15.5.3.2.7. Cryosystems
15.5.3.2.8. Others
15.5.3.3. Rest of Latin America In-Vitro Fertilization Market Revenue (US$ Mn) and Forecasts, By End
Use
15.5.3.3.1. Fertility centers
15.5.3.3.2. Hospitals
15.5.3.3.3. Cryobanks
15.5.3.3.4. Research Laboratories
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Reagents
15.6.3. By
Equipment
15.6.4. By End
Use
16. Competitive Benchmarking
16.1. Brand
Benchmarking
16.2. Market
Share Analysis, 2018
16.3. Global
Presence and Growth Strategies
16.3.1. Mergers
and Acquisitions
16.3.2. Product
Launches
16.3.3. Investments
Trends
16.3.4. R&D
Initiatives
17. Player Profiles
17.1. Cook
Medical Inc.
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. FUJIFILM
Irvine Scientific Inc.
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Genea
Biomedx
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. Thermo
Fisher Scientific Inc.
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. Merck
KGaA (EMD Serono)
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Genea
Limited
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Vitrolife
AB
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. The Baker
Company, Inc.
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. Kitazato
Corporation
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT Analysis
17.9.7. Business
Strategies
17.10. Rocket
Medical PLC.
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Hamilton
Thorne Inc.
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. IVFtech
APS
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business
Strategies
17.13. Green-IVF
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business
Strategies
17.14 Other
industry participants
18. Key Findings
Note: This ToC is tentative and can
be changed according to the research study conducted during the course of
report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.